We’re providing updates on the COVID-19 situation for the UK drug discovery community

Our aim is to help the community during this challenging time and also highlight important work and resources
Find out more >

× Medicines Discovery Catapult

Medicines Discovery Catapult (MDC) is enabling the community to reshape medicines discovery in the UK. It is ambitious, and it is achievable.

We do this by championing innovative life science technology and new approaches, supporting UK innovators to succeed. 

We are helping to industrialise and drive the adoption of new techniques and technologies.

We are driven by helping our community make their mark on the industry and patients.

If you’re involved with medicines discovery in the UK, MDC can almost certainly assist you. Our impact is measured by your success.

Latest News

Accelerated and more efficient drug discovery in psychiatry – the impetus behind a year of upcoming activity between the Psychiatry Consortium and BNA

Psychiatric drug discovery must be a truly collaborative process if it is to be successful. To enable a more unified approach, we need a better

MDC Lighthouse Lab Partner With Levenshulme All-Girl School For British Science Week to Inspire Students into Industry

While student perceptions of careers in science may come with a lack of diversity, the Covid-19 pandemic has highlighted the important contributions made by scientists

Drug Discovery Leader Dr Nicola Heron on Championing Innovation and Diversity in the Sector

Medicines Discovery Catapult’s newly appointed Chief Business Officer, Dr Nicola Heron MBA sets out her intention to support up-and-coming innovators in early stage drug discovery

All News >